Letter: Correspondence on Damle,S.S.,et al. (2025) A Workflow for Transcriptome-Wide Assessment of Antisense Oligonucleotide Selectivity. Nucleic Acid Therapeutics

Duncan-Lewis C , Hartenian E , King V , et al. Cytoplasmic mRNA decay represses RNA polymerase II transcription during early apoptosis. Elife, 2021; 10:e58342; doi: 10.7554/eLife.58342

Smale ST . Transcriptional regulation in the innate immune system. Curr Opin Immunol, 2012; 24:51–57; doi: 10.1016/j.coi.2011.12.008

Shen W , De Hoyos CL , Migawa MT , et al. Chemical modification of PS-ASO therapeutics reduces cellular protein-binding and improves the therapeutic index. Nat Biotechnol, 2019; 37:640–650; doi: 10.1038/s41587-019-0106-2

Pollak AJ , Zhao L , Crooke ST . Systematic analysis of chemical modifications of phosphorothioate antisense oligonucleotides that modulate their innate immune response. Nucleic Acid Ther, 2023; 33:95–107; doi: 10.1089/nat.2022.0067

Lima W , Wu H , Crooke ST , et al. The RNase H Mechanism. In: Antisense Drug Technology—Principles, Strategies, and Applications, 2nd ed (ed.) CRC Press: Boca Raton, FL; 2008; pp. 47–74.

Lima WF , Vickers TA , Nichols J , et al. Defining the factors that contribute to on-target specificity of antisense oligonucleotides. PLoS One, 2014; 9:e101752; doi: 10.1371/journal.pone.0101752

Zhang L , Vickers TA , Sun H , et al. Binding of phosphorothioate oligonucleotides with RNase H1 can cause conformational changes in the protein and alter the interactions of RNase H1 with other proteins. Nucleic Acids Res, 2021; 49:2721–2739; doi: 10.1093/nar/gkab078

Zhang L , Bernardo KD , Vickers TA , et al. NAT10 and DDX21 proteins interact with RNase H1 and affect the performance of phosphorothioate oligonucleotides. Nucleic Acid Ther, 2022; 32:280–299; doi: 10.1089/nat.2021.0107

Doxtader Lacy KA , Liang XH , Zhang L , et al. RNA modifications can affect RNase H1-mediated PS-ASO activity. Mol Ther Nucleic Acids, 2022; 28:814–828; doi: 10.1016/j.omtn.2022.05.024

Vickers TA , Crooke ST . Antisense oligonucleotides capable of promoting specific target mRNA reduction via competing RNase H1-dependent and independent mechanisms. PLoS One, 2014; 9:e108625; doi: 10.1371/journal.pone.0108625

Lima WF , Murray HM , Damle SS , et al. Viable RNaseH1 knockout mice show RNaseH1 is essential for R loop processing, mitochondrial and liver function. Nucleic Acids Res, 2016; 44:5299–5312; doi: 10.1093/nar/gkw350